Factor D (D) is a serine protease, crucial for the activation of the a
lternative complement pathway. Only a limited number of general serine
protease inhibitors are known to inhibit D, most of which covalently
bind to the serine hydroxyl of the catalytic triad. The structure of t
he first enzyme:inhibitor covalent adduct of D with diisopropyl fluoro
phosphate (DIP:D) to a resolution of 2.4 Angstrom is described. The in
hibited enzyme is similar in overall structure to the native enzyme an
d to trypsin, yet exhibits notable differences in the active site. One
region of the active site is conserved between D and trypsin with res
pect to amino-acid sequence and to conformation. Another reflects the
amino-acid substitutions and conformational flexibility between these
enzymes. The active-site histidine residue is observed in the gaucheconformation, not the normal gauche- orientation seen in the classic c
atalytic triad arrangement required for enzymatic activity in serine p
roteases. Comparisons of the active sites between native D, the DIP:D
adduct, and DIP-inhibited trypsin have provided fundamental insights c
urrently being employed in the design of novel small-molecule pharmace
utical agents capable of modulating the alternative complement pathway
.